Literature DB >> 16203090

Impaired hippocampal long-term potentiation in melatonin MT2 receptor-deficient mice.

John Larson1, Ruth E Jessen, Tolga Uz, Ahmet D Arslan, Murat Kurtuncu, Marta Imbesi, Hari Manev.   

Abstract

The pineal product melatonin that acts on specific melatonin receptors has been implicated in pathobiological mechanisms of neuropsychiatric disorders including Alzheimer's disease. We used mice lacking melatonin MT(2) receptors (MT(2) knockouts) to investigate the role of these receptors in synaptic plasticity and learning-dependent behavior. In field CA1 of hippocampal slices from wild-type mice, theta burst stimulation induced robust and stable long-term potentiation that was smaller and decremental in slices from MT(2) knockouts. Tested in an elevated plus-maze on two consecutive days, wild-type mice showed shorter transfer latencies to enter a closed arm on the second day; this experience-dependent behavior did not occur in MT(2) knockouts. These results suggest that MT(2) receptors participate in hippocampal synaptic plasticity and in memory processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203090     DOI: 10.1016/j.neulet.2005.09.040

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  37 in total

Review 1.  Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

Authors:  Magali Dumont; Michael T Lin; M Flint Beal
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

3.  Protective effect of melatonin upon neuropathology, striatal function, and memory ability after intracerebral hemorrhage in rats.

Authors:  Tim Lekic; Richard Hartman; Hugo Rojas; Anatol Manaenko; Wanqiu Chen; Robert Ayer; Jiping Tang; John H Zhang
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

4.  MTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans.

Authors:  Ehm A Andersson; Birgitte Holst; Thomas Sparsø; Niels Grarup; Karina Banasik; Johan Holmkvist; Torben Jørgensen; Knut Borch-Johnsen; Kristoffer L Egerod; Torsten Lauritzen; Thorkild I A Sørensen; Amélie Bonnefond; David Meyre; Philippe Froguel; Thue W Schwartz; Oluf Pedersen; Torben Hansen
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

5.  The MT2 receptor stimulates axonogenesis and enhances synaptic transmission by activating Akt signaling.

Authors:  D Liu; N Wei; H-Y Man; Y Lu; L-Q Zhu; J-Z Wang
Journal:  Cell Death Differ       Date:  2014-12-12       Impact factor: 15.828

6.  Neuroprotection by melatonin after germinal matrix hemorrhage in neonatal rats.

Authors:  Tim Lekic; Anatol Manaenko; William Rolland; Kelly Virbel; Richard Hartman; Jiping Tang; John H Zhang
Journal:  Acta Neurochir Suppl       Date:  2011

Review 7.  MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.

Authors:  Jiabei Liu; Shannon J Clough; Anthony J Hutchinson; Ekue B Adamah-Biassi; Marina Popovska-Gorevski; Margarita L Dubocovich
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

Review 8.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

9.  Drug- and region-specific effects of protracted antidepressant and cocaine treatment on the content of melatonin MT(1) and MT(2) receptor mRNA in the mouse brain.

Authors:  Marta Imbesi; Tolga Uz; Sevim Yildiz; Ahmet D Arslan; Hari Manev
Journal:  Int J Neuroprot Neuroregener       Date:  2006

10.  Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors.

Authors:  Marta Imbesi; Tolga Uz; Svetlana Dzitoyeva; Pietro Giusti; Hari Manev
Journal:  Brain Res       Date:  2008-06-28       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.